19 reports

AVAILABLE Executive 2012; ##(##): ##-##.

  • Renal Cancer
  • Eisai Co., Ltd.
  • Exelixis, Inc.
  • Pfizer Inc.
  • Roche Group

## Alzheimer' s Disease ## Amyotrophic Lateral Sclerosis ## Chronic Renal Failure ## Coronary Artery Disease ## Depression ## Diabetic Retinopathy ## Duchenne Muscular Dystrophy ## Heart Failure ## Liver Fibrosis

  • Diagnostics
  • Mental Health
  • Pathology
  • Renal Cancer
  • SomaLogic, Inc.

Drivers and Their Impact Impact on Key Customer Category Driver Pharmaceutical Stores High Growing Patient Population Special Regulatory Designation for Pipeline Molecules Patient Assistance Programs ## ## ## ## ## Hospitals Low Low ## ## ## ## ## High High Low Low ## ## ## ## ## High Hi

  • Renal Cancer
  • F. Hoffmann-La Roche Ltd.
  • GlaxoSmithKline plc
  • Novartis AG
  • Pfizer Inc.

One patient with pancreatic cancer received ## cycles of LB-## (## weeks); one with thymoma, ## cycles; one with testicular and one with carcinoid of the lung, ## cycles; two with ovarian, ## and ## cycles; and one with NSCLC and one with duodenal c

  • Renal Cancer
  • Therapy
  • United States
  • Product Initiative
  • Exelixis, Inc.

Following the agreement, the companies and the research institutions will create five teams for the treatments of cancer, diabetic nephropathy and mental illnesses including depression.

  • Hepatitis
  • Renal Cancer
  • Japan
  • United States
  • Eisai Co., Ltd.

Hanmi Pharma' s products are used in the treatment of cancer, depression, dementia, dermatology, diabetes, anti-inflammatory, cardiovascular, epilepsy, hepatitis, hypnotics, osteoarthritis, gastrointestinal, osteoporosis and others.

  • Renal Cancer
  • United States
  • World
  • Product Initiative
  • Eisai Co., Ltd.

As of January 2017, the drug candidate was in Phase II stage of development for dysthymia and depression.

  • Renal Cancer
  • United States
  • World
  • Company Sales
  • Product Initiative

As of January 2017, the drug candidate was in Phase II stage of development for dysthymia and depression.

  • Lymphoma
  • Pharmaceutical
  • Renal Cancer
  • Therapy
  • Merck & Co., Inc.

As of January 2017, the drug candidate was in Phase II stage of development for dysthymia and depression.

  • Oncology
  • Renal Cancer
  • United States
  • World
  • Product Initiative
  • Clinical Trial profile. 344 Trial Title

The prominent features of this report are - ##.

  • Clinical Trial
  • Hospital
  • Monoclonal Antibody
  • Renal Cancer
  • Pfizer Inc.

It offers products for neuropsychiatric area, which include anxiety, depression and migraine.

  • Antiviral
  • Renal Cancer
  • Therapy
  • Vaccine
  • Geron Corporation
  • Cervical Cancer
  • PRODUCTS UNDER DEVELOPMENT BY COMPANIES, H2 2016 (CONTD..4)

Lucitanib doses were ##mg/ ##. ##mg/ ##mg/ ##mg (n=##/ ##/ ##/ ##, respectively).

  • Cancer
  • Renal Cancer
  • Therapy
  • United States
  • Product Initiative
  • METASTATIC MELANOMA

Lucitanib doses were ##mg/ ##. ##mg/ ##mg/ ##mg (n=##/ ##/ ##/ ##, respectively).

  • Renal Cancer
  • United States
  • World
  • Company
  • Product Initiative

Lucitanib doses were ##mg/ ##. ##mg/ ##mg/ ##mg (n=##/ ##/ ##/ ##, respectively).

  • Renal Cancer
  • United States
  • Company
  • Company Operations
  • Product Initiative
  • METASTATIC RENAL CELL CARCINOMA - PIPELINE BY RICHTER GEDEON NYRT., H2 2016
  • METASTATIC RENAL CELL CARCINOMA - PIPELINE BY BIONOMICS LIMITED, H2 2016

Its research activities focus exclusively on CNS disorders with key major clinical targets being anxiety, chronic pain, schizophrenia and depression.

  • Cancer
  • Renal Cancer
  • United States
  • Company
  • Product Initiative
  • RENAL CELL CARCINOMA - PIPELINE BY BIONOMICS LIMITED, H1 2016
  • GLOBAL MARKETS DIRECT REPORT COVERAGE

The company discovers and develops drugs for treatment of cancer, and central nervous system disorders such as anxiety, depression and Alzheimer' s disease.

  • Renal Cancer
  • Therapy
  • United States
  • Company
  • Product Initiative
  • Kyowa Hakko Kirin Co., Ltd. - Dormant Developmental Projects,2016

It was also under development for restless leg syndrome and depression.

  • Monoclonal Antibody
  • Renal Cancer
  • Research And Development
  • Therapy
  • Kyowa Hakko Kirin Co., Ltd.
  • RENAL CELL CARCINOMA - PIPELINE BY RICHTER GEDEON NYRT., H2 2016
  • RENAL CELL CARCINOMA - PIPELINE BY BIONOMICS LIMITED, H2 2016

Its research activities focus exclusively on CNS disorders with key major clinical targets being anxiety, chronic pain, schizophrenia and depression.

  • Renal Cancer
  • Therapy
  • United States
  • Company
  • Product Initiative
  • METASTATIC RENAL CELL CARCINOMA - PIPELINE BY BIONOMICS LIMITED, H1 2016

The company discovers and develops drugs for treatment of cancer, and central nervous system disorders such as anxiety, depression and Alzheimer' s disease.

  • Renal Cancer
  • Therapy
  • United States
  • Company
  • Product Initiative